TY - JOUR
T1 - 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
AU - CCS Atrial Fibrillation Guidelines Committee
AU - Andrade, Jason G.
AU - Verma, Atul
AU - Mitchell, L. Brent
AU - Parkash, Ratika
AU - Leblanc, Kori
AU - Atzema, Clare
AU - Healey, Jeff S.
AU - Bell, Alan
AU - Cairns, John
AU - Connolly, Stuart
AU - Cox, Jafna
AU - Dorian, Paul
AU - Gladstone, David
AU - McMurtry, M. Sean
AU - Nair, Girish M.
AU - Pilote, Louise
AU - Sarrazin, Jean Francois
AU - Sharma, Mike
AU - Skanes, Allan
AU - Talajic, Mario
AU - Tsang, Teresa
AU - Verma, Subodh
AU - Wyse, D. George
AU - Nattel, Stanley
AU - Macle, Laurent
N1 - Publisher Copyright:
© 2018 Canadian Cardiovascular Society
PY - 2018/11
Y1 - 2018/11
N2 - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focused Update addresses: (1) anticoagulation in the context of cardioversion of AF; (2) the management of antithrombotic therapy for patients with AF in the context of coronary artery disease; (3) investigation and management of subclinical AF; (4) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (5) acute pharmacological cardioversion of AF; (6) catheter ablation for AF, including patients with concomitant AF and heart failure; and (7) an integrated approach to the patient with AF and modifiable cardiovascular risk factors. The recommendations were developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards. Individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included as Supplementary Material and are available on the CCS Web site. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF guidelines recommendations, from 2010 to the present 2018 Focused Update, which is provided in the Supplementary Material.
AB - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focused Update addresses: (1) anticoagulation in the context of cardioversion of AF; (2) the management of antithrombotic therapy for patients with AF in the context of coronary artery disease; (3) investigation and management of subclinical AF; (4) the use of antidotes for the reversal of non-vitamin K antagonist oral anticoagulants; (5) acute pharmacological cardioversion of AF; (6) catheter ablation for AF, including patients with concomitant AF and heart failure; and (7) an integrated approach to the patient with AF and modifiable cardiovascular risk factors. The recommendations were developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) standards. Individual studies and literature were reviewed for quality and bias; the literature review process and evidence tables are included as Supplementary Material and are available on the CCS Web site. Details of the updated recommendations are presented, along with their background and rationale. This document is linked to an updated summary of all CCS AF guidelines recommendations, from 2010 to the present 2018 Focused Update, which is provided in the Supplementary Material.
UR - http://www.scopus.com/inward/record.url?scp=85055741307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055741307&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2018.08.026
DO - 10.1016/j.cjca.2018.08.026
M3 - Article
C2 - 30404743
AN - SCOPUS:85055741307
SN - 0828-282X
VL - 34
SP - 1371
EP - 1392
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 11
ER -